A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
University of Nebraska
University of Nebraska
EMD Serono
Fundación de investigación HM
M.D. Anderson Cancer Center
University College, London
Mayo Clinic
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Essen Biotech
Baptist Health South Florida
University of Alabama at Birmingham
Mayo Clinic
Var2 Pharmaceuticals
M.D. Anderson Cancer Center
Jazz Pharmaceuticals
Degron Therapeutics Co.
Turning Point Therapeutics, Inc.
M.D. Anderson Cancer Center
Northwestern University
University Hospital, Essen
Stanford University
Sheffield Teaching Hospitals NHS Foundation Trust